Works by Vetrone, Luigia

Results: 6

Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma.

Published in:

2019

By:

De Felice, Francesca;
Vetrone, Luigia;
Bulzonetti, Nadia;
Caiazzo, Rossella;
Marampon, Francesco;
Musio, Daniela;
Tombolini, Vincenzo

Publication type:

journal article

A novel tool for predicting the dose distribution of non‐sealed 188Re (Rhenium) resin in non‐melanoma skin cancers (NMSC) patients.

Published in:

Medical Physics, 2023, v. 50, n. 7, p. 4600, doi. 10.1002/mp.16346

By:

Zagni, Federico;
Vichi, Sara;
Paolani, Giulia;
Santoro, Miriam;
Della Gala, Giuseppe;
Strolin, Silvia;
Castellucci, Paolo;
Vetrone, Luigia;
Fanti, Stefano;
Morganti, Alessio Giuseppe;
Strigari, Lidia

Publication type:

Article

Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1324631

By:

Droghetti, Matteo;
Bianchi, Lorenzo;
Presutti, Massimiliano;
Vetrone, Luigia;
Farolfi, Andrea;
Mei, Riccardo;
Giunchi, Francesca;
Degiovanni, Alessio;
Mottaran, Angelo;
Piazza, Pietro;
Cangemi, Danilo;
Castellucci, Paolo;
D’Errico, Antonietta;
Schiavina, Riccardo;
Brunocilla, Eugenio;
Fanti, Stefano

Publication type:

Article

Feasibility of 177Lu-PSMA Administration as Outpatient Procedure for Prostate Cancer.

Published in:

2024

By:

Zagni, Federico;
Vetrone, Luigia;
Farolfi, Andrea;
Vadalà, Maria;
Rizzini, Elisa Lodi;
Golemi, Arber;
Strigari, Lidia;
Fanti, Stefano

Publication type:

Editorial

[68Ga]Ga-PSMA-11 PET/CT–Positive Hepatic Inflammatory Pseudotumor: Possible PSMA-Avid Pitfall in Nuclear Imaging.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 10, p. 1658, doi. 10.2967/jnumed.124.267518

By:

Monastero, Fabio;
Vetrone, Luigia;
Cardisciani, Lina;
Renzulli, Matteo;
Prosperi, Enrico;
Cescon, Matteo;
Ravaioli, Matteo;
Fanti, Stefano;
Farolfi, Andrea;
Vasuri, Francesco

Publication type:

Article

Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68 Ga-PSMA PET/CT Features in Primary Staging.

Published in:

Cancers, 2023, v. 15, n. 6, p. 1716, doi. 10.3390/cancers15061716

By:

Vetrone, Luigia;
Mei, Riccardo;
Bianchi, Lorenzo;
Giunchi, Francesca;
Farolfi, Andrea;
Castellucci, Paolo;
Droghetti, Matteo;
Presutti, Massimiliano;
Degiovanni, Alessio;
Schiavina, Riccardo;
Brunocilla, Eugenio;
D'Errico, Antonietta;
Fanti, Stefano

Publication type:

Article

Works by Vetrone, Luigia

Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma.

A novel tool for predicting the dose distribution of non‐sealed <sup>188</sup>Re (Rhenium) resin in non‐melanoma skin cancers (NMSC) patients.

Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection.

Feasibility of <sup>177</sup>Lu-PSMA Administration as Outpatient Procedure for Prostate Cancer.

[<sup>68</sup>Ga]Ga-PSMA-11 PET/CT–Positive Hepatic Inflammatory Pseudotumor: Possible PSMA-Avid Pitfall in Nuclear Imaging.

Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68 Ga-PSMA PET/CT Features in Primary Staging.